![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 17")
Medical vs. Recreational Cannabis Use: Survey Reveals Overlap
A community survey of 709 cannabis users in Ontario before Canadian legalization reveals that most self-identified medical users also use recreationally, and that medical users report far higher rates of daily use and psychiatric symptoms — but only 23%…
Cannabis Use in Older Adults: Guidance Gap After Legalization
A peer-reviewed qualitative study from Health Promotion and Chronic Disease Prevention in Canada finds that older adults use cannabis mainly for therapeutic reasons but are left without reliable guidance from clinicians—a gap with real safety…
Thailand Cannabis Knowledge Gap: Thai Border Survey 2024
A 618-person survey at a northeastern Thai border hospital reveals that cannabis legalization awareness far outpaces actual knowledge of medical indications and safety risks—with over 60% unable to answer basic questions correctly.
DMT, Cannabis Dementia Risk, Valbenazine Elderly: 2025 Evidence
Three studies summarized in a clinical newsletter raise intriguing signals about vaporized DMT for depression, cannabis-linked dementia risk in older adults, and valbenazine for tardive dyskinesia—but each comes with design limitations that caution…
Cannabis Clinics vs GPs: Australian Patient Satisfaction Survey 2025
A large Australian online survey finds that patients accessing medicinal cannabis through specialty clinics differ markedly from those treated by generalist physicians—and report lower satisfaction across all measured care dimensions. The observational…
Cannabis and Dementia Risk in Older Adults: 2026 Cohort Study
A large observational and genetic study finds no evidence that cannabis use accelerates cognitive aging or raises dementia risk in older adults—but crude exposure measurement and cohort bias mean this is not a clean bill of health.
Cannabis Extract for Chronic Pain: ESCAPE Study Reviewed
Pain scores fell and quality of life improved in a small German observational study of a 1:1 THC:CBD cannabis extract — but without a control group, no one can say whether the extract caused the benefit.
Cannabis Use Among Adults Over 50: Prevalence and Medical Use Data
A nationally representative analysis of the 2018 Health and Retirement Study finds that nearly 1 in 5 Americans aged 50–64 used cannabis, with smoking the dominant method and minimal clinical oversight—raising important questions for clinicians caring…
COVID-19 Alcohol and Cannabis Use: Income, Race, Gender Intersections
Nine consecutive surveys of Canadian adults reveal that the relationship between socio-economic status and pandemic-era alcohol and cannabis use is more complex than previously assumed—shaped significantly by gender, ethnoracial background, and age.
Cannabis Use and Depression: What 47,000 Adults Show
Researchers analyzed 2021 NSDUH data from 47,291 US adults and found associations between cannabis use—even mild use—and major depressive episodes. But the study's cross-sectional design means causation cannot be inferred, and its policy recommendations…